INTRODUCTION

A highly potent synthetic growth hormone-releasing hormone (GHRH). It is FDA-approved specifically for reducing visceral abdominal fat in HIV-associated lipodystrophy. Widely used off-label for aggressive fat loss and body composition.

What is this used for?

Visceral Fat Reduction

Visceral Fat Reduction

FDA-approved for reducing deep, visceral adipose tissue. It operates by stimulating intense pulses of natural growth hormone.

Body Composition & Muscle

Body Composition & Muscle

Studied for improving lean muscle mass and overall body composition due to its strong GH-stimulating properties.

Cognitive Recovery

Cognitive Recovery

Recent clinical trials have explored Tesamorelin for improving cognitive function in patients with mild cognitive impairment.

What dose is typical for your goal?

Typical dose
1.4–2 mg
How it's taken
Injection under the skin
How often
Once daily before bed
Most common starting point
1.4 mg daily (FDA-approved EGRIFTA SV dose)

Based on published studies and what providers typically prescribe.

Important safety info

  • FDA-approved only for HIV-associated lipodystrophy. Egrifta SV labeling explicitly states it "has a weight neutral effect" — not indicated for general weight loss.
  • Contraindicated in active malignancy, pregnancy, and disruption of the hypothalamic-pituitary axis.
  • Elevates IGF-1 — baseline and periodic IGF-1 monitoring is recommended.

These are typical doses from research and real prescriptions — not a recommendation for you specifically. Your provider will adjust based on your body, your goals, and your health history.

Want your exact dose? A provider will personalize this for you.

Find a Provider

How do you take it?

RouteInjection under the skin
FrequencyOnce daily (usually before bed)
Important Note

These are typical doses from research and real prescriptions — not a recommendation for you specifically. Your provider will adjust based on your body, your goals, and your health history.

What to expect

1 / 4

Week 1-2

Growth hormone levels begin to increase. Sleep quality often improves first.

Week 3-6

Gradual reduction in visceral fat. Energy and recovery improvements.

Month 2-3

Visible body composition changes. Reduced abdominal fat is the primary benefit.

Month 3+

FDA-studied for long-term use. Many providers run 6-12 month protocols.

Individual experiences vary. Results depend on your body, goals, and protocol adherence.

How well researched is this?

FDA Approved Medication

FDA-approved under the brand name Egrifta. Robust phase 3 clinical trials confirming specific visceral fat reduction.

Want the full breakdown? Read our comprehensive analysis.
Read Evidence Review →

Purity

Purity measures how clean and accurate the compound is. Higher purity means fewer contaminants and more reliable dosing.

>99.0%

HPLC Purity Tested

Always require a Certificate of Analysis (CoA) from a US-based compounding pharmacy.

Common questions

Ready to start?

Consult with a licensed provider to determine the right protocol for your goals.